Kourous Rezaei
Directeur/Membre du Conseil chez American Society of Retinal Specialists
Profil
Kourous A.
Rezaei is currently the Director at the American Society of Retinal Specialists and the Principal at Illinois Retina Associates SC.
He was previously the Director-Vitreoretinal Fellowship Program at The University of Chicago and an Associate Professor at Rush University Medical Center.
He also served as the Chief Medical Officer & Senior Vice President at IVERIC bio, Inc. from 2015 to 2020.
Rezaei completed his undergraduate degree at Cologne University of Applied Sciences.
Postes actifs de Kourous Rezaei
Sociétés | Poste | Début |
---|---|---|
Illinois Retina Associates SC
Illinois Retina Associates SC Medical/Nursing ServicesHealth Services Illinois Retina Associates SC engages in the diagnosing and treating diseases of the retina, macula and vitreous. It offers retinal exam, retinal laser treatment, intravitreal injections, optical coherence tomography, and ultrasound. The company was founded by David H. Orth in 1976 and is headquartered in Harvey, IL. | Corporate Officer/Principal | 01/01/2005 |
American Society of Retinal Specialists | Directeur/Membre du Conseil | - |
Anciens postes connus de Kourous Rezaei
Sociétés | Poste | Fin |
---|---|---|
IVERIC BIO, INC. | Directeur Technique/Scientifique/R&D | 01/12/2020 |
The University of Chicago | Corporate Officer/Principal | - |
Rush University Medical Center
Rush University Medical Center Medical/Nursing ServicesHealth Services Rush University Medical Center engages in the provision of health care services. The company was founded in 1972 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
Formation de Kourous Rezaei
Cologne University of Applied Sciences | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
IVERIC bio, Inc.
IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Rush University Medical Center
Rush University Medical Center Medical/Nursing ServicesHealth Services Rush University Medical Center engages in the provision of health care services. The company was founded in 1972 and is headquartered in Chicago, IL. | Health Services |
Illinois Retina Associates SC
Illinois Retina Associates SC Medical/Nursing ServicesHealth Services Illinois Retina Associates SC engages in the diagnosing and treating diseases of the retina, macula and vitreous. It offers retinal exam, retinal laser treatment, intravitreal injections, optical coherence tomography, and ultrasound. The company was founded by David H. Orth in 1976 and is headquartered in Harvey, IL. | Health Services |
American Society of Retinal Specialists |